This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In an interview, Cherokee Layson-Wolf, PharmD, BCACP, FAPhA, professor of practice, sciences, and health outcomes research at the University of Maryland, explored the evolving landscape of vaccine recommendations, emphasizing the critical role pharmacists play in guiding patients through complex medical information.
In a vote of 5 to 1 on Thursday, members of the Advisory Committee on Immunization Practices (ACIP) voted to recommend against influenza vaccine containing the preservative thimerosal. The recommendations include all US adults as well as recommending pregnant women also receive a thimerosal-free vaccine for influenza.
In an interview on vaccine recommendations, health care professionals expressed growing concerns about the changing landscape of medical information dissemination. Health care professionals emphasize patient education and reliable information in the evolving vaccine recommendation landscape.
In 2022, the Advisory Committee on Immunization Practices (ACIP) published updated pneumococcal vaccine recommendations. In 2022, the Advisory Committee on Immunization Practices (ACIP) published updated pneumococcal vaccine recommendations.
Garofoli, PharmD, BCACP, CTTS, FAPhA Publication Article Drug Topics Journal Drug Topics May/June 2025 Volume 169 Issue 03 Pharmacy team members can help patients prepare for upcoming travels, ensuring they are up to date with the recommended vaccines for their locations. The first resource is the CDC’s Yellow Book.
Experts discuss the recent dismissal of all 17 members of the Advisory Committee on Immunization Practices (ACIP), a panel that provides guidance to the CDC on vaccine recommendations. This abrupt change has raised significant concerns within the health care community about the potential impact on vaccine trust and public health policy.
With significant progress made in researchers’ understanding of dermatological diseases, a pathway has been made for the development of targeted vaccines, according to data published in Vaccines. 5 Throughout the past 10 years, development of vaccines for preventing skin diseases has made significant progress.
Rite Aid, which was once the third largest pharmacy chain in the United States, announced in May that it filed its second chapter 11 bankruptcy in under 2 years. Drug Topics : How has the closure of Rite Aid stores impacted independentpharmacies in Pennsylvania? Rob Frankil, RPh : I'm seeing a mixed bag.
The FDA has approved a prefilled syringe format of the recombinant zoster vaccine Shingrix for the prevention of shingles, GSK said in a release. 1 The company said approval of the new presentation was based on data that showed comparability between the new and existing version of the vaccine.
Pharmacy Technicians Could Enhance Public Health by Becoming ‘Vaccine Champions’ Killian Meara October 3rd 2024 Article Researchers suggest that vaccine champion programs could be a promising avenue to increasing immunization rates.
McKesson ideaShare 2025 brought thousands of independent pharmacists, pharmacy owners, technicians, and industry leaders together in Nashville, Tennessee, shining a spotlight on innovation and advocacy in community pharmacy.
Strategies for IndependentPharmacies to Harness Consumer Trends and Meet the Competition Peter Koo, PharmD May 19th 2025 Article Pharmacies face mounting challenges amid increased competition, rising operational costs, and complex reimbursement models. 2013;3(4):e002361. 2013;3(4):e002361.
Because technicians often understand daily pharmacy operations more intimately than pharmacists, they should be involved in decisions related to workflow, technology, and design. Many independentpharmacies already do this well, but larger chains need to catch up.
News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy (..)
Vaccine Coverage Remains Low Among Forcibly Displaced Children Brian Nowosielski June 17th 2025 Article Researchers conducted a systematic review and meta-analysis to estimate vaccine coverage and identify factors associated with vaccination among forcibly displaced, pediatric populations. Published online June 6, 2025.
The software integrates directly with existing pharmacy management systems and features adherence monitoring, vaccine registry integration, performance measure tracking, an administrative assistant powered by AI, and more.
ACIP Votes to Expand RSV Vaccine Recommendation to Include Adults 50 Years and Older Ashley Gallagher April 17th 2025 Article Currently, the recommendation is for patients 75 years and older and those aged 60 to 74 years with an increased risk of severe respiratory syncytial virus.
Related Content Pharmacy Technicians Could Enhance Public Health by Becoming ‘Vaccine Champions’ Killian Meara October 3rd 2024 Article Researchers suggest that vaccine champion programs could be a promising avenue to increasing immunization rates. J Am Pharm Assoc (2003). 2025 May 9:102419. doi: 10.1016/j.japh.2025.102419.
News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)
Kevin Cleveland, PharmD, professor at Idaho State University, explores the potential impacts of changes to the Advisory Committee on Immunization Practices (ACIP), highlighting concerns about shifting medical guidance and vaccine recommendations. Cleveland: So I'll start as a provider.
Q&A: Prioritizing Pharmacy Technician Well-Being Killian Meara ; Taylor Watterson, PharmD, PhD June 20th 2025 Article Taylor Watterson, PharmD, PhD, discusses the primary contributors to stress or frustration among pharmacy technicians and how to fix them.
Ensuring patients are current on MMR vaccines is crucial due to global measles outbreaks, with specific recommendations for international travelers. SHOW MORE As summer heats up, pharmacists can provide travel vaccines and other recommendations.
link] Recent Videos Related Content Q&A: Expert Highlights Importance of Trusted Sources for Vaccine Information Ashley Gallagher ; Laura Knockel, PharmD, BCACP July 6th 2025 Article Health care professionals emphasize patient education and reliable information in the evolving vaccine recommendation landscape.
Harvard Poll Shows 1 in 5 Adults Do Not Support Routine Childhood Vaccine Requirements Ashley Gallagher June 30th 2025 Article Of those who do not support vaccines, 79% said a major reason for their opposition is that it should be the parents’ choice about whether to vaccinate their child and 40% cite safety concerns.
FDA Approves New Moderna COVID-19 Vaccine for Older Adults, High-Risk Patients Ashley Gallagher June 2nd 2025 Article The new approval is in line with recommendations that suggest booster vaccination for older adults and patients aged 12 to 64 with at least 1 or more underlying risk factors.
Exclusion criteria included having a bleeding disorder or having received any vaccine or monoclonal antibody for the prevention of RSV. Patients were included if they were a healthy early or moderate pre-term infant or late pre-term or full-term infant.
Key exclusion criteria included prior receipt of an HIV vaccine, prior use of long-acting systemic PrEP therapy, or prior use of HIV postexposure prophylaxis therapy. Passport to Protection: Best Practices for Travel Vaccines in the Pharmacy Setting Gretchen K.
News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)
21 / stock.adobe.com READ MORE: Progress in Dermatology Paves the Way for Vaccine Development While essential for the treatment of skin conditions like AD, each variation of TCSs is classified by its strength and risk of adverse effects. image credit: jittawit.21 J Clin Med. 2023 Oct 27;12(21):6813. doi: 10.3390/jcm12216813.
News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)
Saturday, August 2 at 2 PM Raising Your Voice in Support of Global Childhood Immunization Programs Rebecca Maxie, MPS, explores global childhood vaccination challenges and the federal appropriations process. Click here to learn more about the NPhA Annual Meeting.
Cidara Therapeutics Announces Positive Topline Results from its Phase 2b NAVIGATE Trial Evaluating CD388, a Non-Vaccine Preventative of Seasonal Influenza. Sign up today for our free Drug Topics newsletter. References 1. News release. Cidara Therapeutics. June 23, 2025. Accessed June 26, 2025.
READ MORE: Q&A: Myths, Misinformation Surrounding Hepatitis Vaccines The study cohort included 283 patients 12 years of age or older with an acute HCV Infection who were treatment-naïve. Passport to Protection: Best Practices for Travel Vaccines in the Pharmacy Setting Gretchen K.
FDA Approves New Moderna COVID-19 Vaccine for Older Adults, High-Risk Patients Ashley Gallagher June 2nd 2025 Article The new approval is in line with recommendations that suggest booster vaccination for older adults and patients aged 12 to 64 with at least 1 or more underlying risk factors.
She admitted she was using them for injection drug use, and I gave her 5 syringes we were using for COVID-19 vaccine injections that were provided by the government. She was most grateful and assured me she was going to seek help the next day.
In a new CDC report, investigators found that there was no connection between thimerosal in vaccines and autism or other neurodevelopmental conditions. Thimerosal is a mercury-containing compound that has been widely used as a preservative in some biological and drug products since the 1930s.
Become a wellness center rather than “just a pharmacy” Independentpharmacies have a significant opportunity to evolve beyond simply fulfilling prescriptions. Here’s how to turn your pharmacy into a destination for personalized care, prevention, and holistic health support.
Investigators found that incorporating either the pneumococcal conjugate vaccine (PCV) 20 or PCV 15 and the 23-valent pneumococcal polysaccharide vaccine (PPSV23) had an incremental budget impact of $6.5 2,3 In June 2024, the ACIP announced updates to the vaccine schedule to prevent invasive pneumococcal disease.
503b Dispensing 503b dispensing can help your pharmacy grow by offering sterile compounded products WITHOUT being a sterile compounder. Compounding Services Compounding isnt just for niche needs anymore. Common Compounds to Offer: Hormone replacement therapy (HRT) Pediatric formulations Dermatology compounds (e.g.,
The pollution includes fine particulate matter, ozone, nitrogen oxides, and volatile organic compounds, all of which can be transported in a smoke plume miles away from the actual fire.” These particles are invisible to the naked eye, and as opposed to larger particles that may only reach the back of the throat, PM2.5
FDA Approves New Moderna COVID-19 Vaccine for Older Adults, High-Risk Patients Ashley Gallagher June 2nd 2025 Article The new approval is in line with recommendations that suggest booster vaccination for older adults and patients aged 12 to 64 with at least 1 or more underlying risk factors.
Sweden’s move from the 13-valent pneumococcal conjugate vaccine (PCV13) to PCV10 in 2019 is most likely responsible for the uptick in pHUS cases because of changes in serotype coverage. In the US, recommendations are slightly different, with PCV13 being the safest and most effective pneumococcal vaccine for both children and adults.
Of these cases, 96% were reported in patients who were unvaccinated or had unknown vaccination status. 1 Building trust with patients through fact-based information could help boost vaccination rates to the desirable coverage. After the vaccine became available in 1963, the CDC tried to eliminate measles in the US by 1982.
Expanding Services Critical for Independent PharmaciesDouglas Hoey, CEO of the National Community Pharmacists Association (NCPA), discussed what pharmacies can do to increase revenue and avoid shutting their doors, as well as the importance of independentpharmacies in the health care landscape.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content